{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-253754","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.720518+00:00","generated_at":"2026-05-30T02:47:47.054422+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CalciMedica appoints Stephen Bardin as CFO; Dan Geffken resigns as interim CFO","bullets":["Dan Geffken resigned as interim CFO effective after filing Q3 2024 10-Q.","Stephen Bardin appointed CFO, principal financial and accounting officer; previously a consultant since April 2024.","Bardin served as CFO of ATAI Life Sciences (2022-2024) and SVP Finance at BridgeBio (2022).","Compensation: $380k base salary, $20k signing bonus, 100k stock option and 40k RSUs granted.","Option vests 25% on Oct 1, 2025 then monthly; RSUs vest 25% on Oct 1, 2025 then quarterly."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-253754","json":"https://secwatch.observer/filing/0001193125-24-253754.json","markdown":"https://secwatch.observer/filing/0001193125-24-253754.md","text":"https://secwatch.observer/filing/0001193125-24-253754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/d862451d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:47:47.054422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd5f8e442a","claim":"Dan Geffken resigned as interim Chief Financial Officer at CalciMedica, Inc..","evidence_excerpt":"Dan Geffken tendered his resignation as interim Chief Financial Officer, principal financial officer and principal accounting officer of CalciMedica, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e34358b13e","claim":"Stephen Bardin was appointed as Chief Financial Officer at CalciMedica, Inc..","evidence_excerpt":"the Company’s board of directors (the “Board”) appointed Stephen Bardin as the Company’s Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}